Journal article

Enhanced Proteolytic Clearance of Plasma A beta by Peripherally Administered Neprilysin Does Not Result in Reduced Levels of Brain A beta in Mice

John R Walker, Reynand Pacoma, James Watson, Weijia Ou, Juliano Alves, Daniel E Mason, Eric C Peters, Hugo D Urbina, Gus Welzel, Alana Althage, Bo Liu, Tove Tuntland, Laura H Jacobson, Jennifer L Harris, Andrew M Schumacher

JOURNAL OF NEUROSCIENCE | SOC NEUROSCIENCE | Published : 2013

Abstract

Accumulation of β-amyloid (Aβ) in the brain is believed to contribute to the pathology of Alzheimer's Disease (AD). Aβ levels are controlled by the production of Aβ from amyloid precursor protein, degradation by proteases, and peripheral clearance. In this study we sought to determine whether enhancing clearance of plasma Aβ with a peripherally administered Aβ-degrading protease would reduce brain Aβ levels through a peripheral sink. Neprilysin (NEP) is a zinc-dependent metalloprotease that is one of the key Aβ-degrading enzymes in the brain. We developed a NEP fusion protein with in vitro degradation of Aβ and a 10 day plasma half-life in mouse. Intravenous administration of NEP to wild-typ..

View full abstract